Several mechanisms, such as P53-mediated transcriptional regulation (Benetatos et al., 2011) and promoter region CpG island hypermethylation (Braconi et al., 2011; Lu et al., 2013), have been reported to repress MEG3 expression in different tumor types and tumor cell lines. Here, MEG3 is linked to neoplasm.